Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series

被引:0
|
作者
Skoberne, Andrej [1 ,3 ]
Skerget, Matevz [2 ,3 ]
Kojc, Nika [4 ]
Frelih, Maja [4 ]
Rigler, Andreja Ales [1 ,3 ]
Haler, Zeljka Veceric [1 ,3 ]
Borstnar, Spela [1 ,3 ]
Rotar, Nusa Avgustin [1 ,3 ]
Kova, Damjan [1 ,3 ]
Lindi, Jelka [1 ,3 ]
Zver, Samo [2 ,3 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Zaloska Cesta 7, Ljubljana 1000, Slovenia
[2] Univ Med Ctr Ljubljana, Dept Hematol, Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[4] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia
关键词
anti-factor H autoantibody; C5b-9; cryoglobulins; proliferative glomerulonephritis with monoclonal immunoglobulin; deposits; eculizumab; GLOMERULONEPHRITIS;
D O I
10.5414/CNP96S03
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Monoclonal gammopathy of renal significance (MGRS) denotes kidney diseases caused by monoclonal immunoglobulins in patients who do not have an overt hematological malignancy. Treatment is primarily directed against the underlying clone. Complement activation and cryoglobulinemia are known factors that can contribute to tissue damage, however, the full extent of their involvement is not clear. Materials and methods: This was a retrospective study including all patients with MGRS referred for consultation to our hospital over a 3-year period. Results: We identified 17 patients, of which 12 had proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Treatment with anti-clonal or immunosuppressive therapy was successful in 60% of patients with PGNMID, and treatment success was more common in patients with lambda chain (100%) compared to kappa chain deposits (20%). Serum markers of complement involvement were identified in 41% of all patients (88% of tested samples), most commonly high serum C5b-9 values or anti-factor H autoantibodies (both 24%). Patients with complement involvement did not respond well to treatment, which was unsuccessful in all treated patients with anti-factor H autoantibodies and 75% of patients with high serum C5b-9 values. Cryoglobulinemia was identified in 29% of all patients (71% tested samples) and was monoclonal in 40% of positive cases and mixed in 60%. None of the patients with cryoglobulinemia had organized deposits, however, there was a trend toward more common intramembranous deposits. In patients with monoclonal cryoglobulinemia both anti-clonal and immunosuppressive treatment were unsuccessful. All patients with mixed cryoglobulinemia were treated successfully with immunosuppressive therapy. Conclusion: Treatment of patients with PGNMID was successful in most cases. Complement involvement as well as monoclonal and mixed cryoglobulinemia were relatively common in our cohort, with the first two generally associated with unsuccessful treatment and the latter with successful treatment.
引用
收藏
页码:S16 / S23
页数:8
相关论文
共 50 条
  • [21] Monoclonal gammopathy of renal significance from the perspective of nephrologists
    Park, Kootae
    Kwon, Soon Hyo
    BLOOD RESEARCH, 2024, 59 (01)
  • [23] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS FROM MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE
    Puli, Amoghavarsha
    Bastacky, Sheldon
    Veldkamp, Peter
    Smith, Roy
    Liang, Kelly
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 576 - 576
  • [24] MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE: A CASE OF MINIMAL CHANGE DISEASE
    Mathew, Ajay
    Lamarche, Jorge
    Peguero, Alfredo
    Courville, Craig
    Taha, Mohamed
    Antar-Shultz, Marina
    Wheeler, Donald
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A71 - A71
  • [25] A RARE CASE OF IMMUNOTACTOID GLOMERULOPATHY IN MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE
    Alshoubaki, Nawras
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 545 - 546
  • [26] Diagnosis of monoclonal gammopathy of renal significance
    Bridoux, Frank
    Leung, Nelson
    Hutchison, Colin A.
    Touchard, Guy
    Sethi, Sanjeev
    Fermand, Jean-Paul
    Picken, Maria M.
    Herrera, Guillermo A.
    Kastritis, Efstathios
    Merlini, Giampaolo
    Roussel, Murielle
    Fervenza, Fernando C.
    Dispenzieri, Angela
    Kyle, Robert A.
    Nasr, Samih H.
    KIDNEY INTERNATIONAL, 2015, 87 (04) : 698 - 711
  • [27] Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report
    Ventura, Sofia
    Cabral, Raquel
    Viveiros, Carolina
    Santos, Mariana S.
    Esteves, Joao
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [28] Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case
    Tewari, Rohit
    Chatterjee, Tathagat
    Mendonca, Satish
    Dogra, Manu
    Pramanik, Suman Kumar
    Yanamandra, Uday
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (02) : 298 - 306
  • [29] A case of immunotactoid glomerulopathy in a patient with monoclonal gammopathy of renal significance
    Campdesuner, Victoria
    Teklie, Yeshanew
    Lattanzio, Natalia
    Lorenzo, Christian
    Bell, Stephen
    Rodriguez, Yorlenis
    Sastry, Ashok
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (01): : 60 - 64
  • [30] Update on monoclonal gammopathy of renal significance
    Buettner-Herold, M.
    Pfister, F.
    Amann, K.
    NEPHROLOGE, 2019, 14 (01): : 14 - 25